Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01030757 · ClinicalTrials.gov registry record · Phase 2
Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver
A Phase 2 study, sponsored by New Mexico Cancer Research Alliance.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT01030757: Clinical Trial Phase 2 study, sponsored by New Mexico Cancer Research Alliance.
NCT01030757 is a Phase 2 study that was terminated before completion, run by New Mexico Cancer Research Alliance. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01030757, a Phase 2 study, was terminated before completion, sponsored by New Mexico Cancer Research Alliance.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the response of liver tumors to radiation therapy using Tomotherapy.
Interventions
- RADIATION Tomotherapy treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-05 |
| Phase | Phase 2 |
Why NCT01030757 stopped before completion
NCT01030757 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Tomotherapy treatment is the first listed.
NCT01030757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01030757 about?
NCT01030757 is a clinical study titled "Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver". The purpose of this study is to determine the response of liver tumors to radiation therapy using Tomotherapy.
What is the current status of trial NCT01030757?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2009-06. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01030757?
The interventions under investigation include: Tomotherapy treatment (RADIATION).
Who is sponsoring clinical trial NCT01030757?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01030757's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia